Antiserum against the conserved nine amino acid N-terminal peptide of influenza a virus matrix protein 2 is not immunoprotective

Journal of General Virology

Volumn 92, Issue 2, 2011, Pages 301-306

  De Filette, Marina ^a,b   Ysenbaert, Tine ^a,b   Roose, Kenny ^a,b   Schotsaert, Michael ^a,b   Roels, Stefan ^c   Goossens, Els ^c   Schepens, Bert ^a,b   Fiers, Walter ^a,b   Saelens, Xavier ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTISERUM; KEYHOLE LIMPET HEMOCYANIN; SERYLLEUCYLLEUCYLTHREONYLGLUTAMYLVALYLGLUTAMYLTHREONYLPROLINE; SERYLLEUCYLLEUCYLTHREONYLGLUTAMYLVALYLGLUTAMYLTHREONYLPROLYLISOLEUCYLARGINYLASPA RAGINYLGLUTAMYLTRYPTOPHYLGLYCYLCYSTEINYLARGINYLCYSTEINYLASPARAGINYLASPARTYLSERYL SERYLASPARTATE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; INFLUENZA A; INFLUENZA VIRUS A; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; WEIGHT REDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; DOGS; GENE EXPRESSION REGULATION, VIRAL; HEMOCYANIN; IMMUNE SERA; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; RABBITS; VIRAL MATRIX PROTEINS;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE; ORYCTOLAGUS CUNICULUS; SWINE INFLUENZA VIRUS;

EID: 79251484996     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.027086-0     Document Type: Article

References (18)

1. Bucher, D., Popple, S., Baer, M., Mikhail, A., Gong, Y. F., Whitaker, C., Paoletti, E. & Judd, A. (1989). M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies. J Virol 63, 3622-3633. (Pubitemid 19205431)
2. Darnule, T. V., Likhite, V., Darnule, A. T., Turino, G. M. & Mandl, I. (1980). Enhancement of humoral immune response against human lung elastin peptides. Experientia 36, 606-607.
3. Dawood, F. S., Jain, S., Finelli, L., Shaw, M. W., Lindstrom, S., Garten, R. J., Gubareva, L. V., Xu, X., Bridges, C. B. & Uyeki, T. M. (2009). Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360, 2605-2615.
4. De Filette, M., Min Jou, W., Birkett, A., Lyons, K., Schultz, B., Tonkyro, A., Resch, S. & Fiers, W. (2005). Universal influenza A vaccine: optimization of M2-based constructs. Virology 337, 149-161.
5. Fiore, A. E., Bridges, C. B. & Cox, N. J. (2009). Seasonal influenza vaccines. Curr Top Microbiol Immunol 333, 43-82.
6. Grebe, K. M., Yewdell, J. W. & Bennink, J. R. (2008). Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect 10, 1024-1029.
7. Hanly, W. C., Artwohl, J. E. & Bennett, B. T. (1995). Review of polyclonal antibody production procedures in mammals and poultry. ILAR J 37, 93-118.
8. Jegerlehner, A., Schmitz, N., Storni, T. & Bachmann, M. F. (2004). Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 172, 5598-5605.
9. Lamb, R. A., Zebedee, S. L. & Richardson, C. D. (1985). Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40, 627-633.
10. Mera, K., Nagai, M., Brock, J. W., Fujiwara, Y., Murata, T., Maruyama, T., Baynes, J. W., Otagiri, M. & Nagai, R. (2008). Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products. J Immunol Methods 334, 82-90.
11. Mozdzanowska, K., Feng, J., Eid, M., Kragol, G., Cudic, M., Otvos, L., Jr & Gerhard, W. (2003). Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 21, 2616-2626.
12. Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M. & Fiers, W. (1999). A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5, 1157-1163.
13. Pinto, L. H., Holsinger, L. J. & Lamb, R. A. (1992). Influenza virus M2 protein has ion channel activity. Cell 69, 517-528.
14. Reed, L. J. & Muench, H. (1938). A simple method for estimating fifty percent endpoints. Am J Hyg 27, 493-497.
15. Schulze, I. T. (1970). The structure of influenza virus. I. The polypeptides of the virion. Virology 42, 890-904.
16. Wang, R., Song, A., Levin, J., Dennis, D., Zhang, N. J., Yoshida, H., Koriazova, L., Madura, L., Shapiro, L. & other authors (2008). Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein. Antiviral Res 80, 168-177.
17. Webster, R. G. & Hinshaw, V. S. (1977). Matrix protein from influenza A virus and its role in cross-protection in mice. Infect Immun 17, 561-566.
18. Zebedee, S. L. & Lamb, R. A. (1989). Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc Natl Acad Sci U S A 86, 1061-1065.